Job Description
Company description:
Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 30 years of experience in viral vectors, the driving force behind the majority of gene therapies.
Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).
Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
Job description:
AtOXB, our people are at the heart of everything we do. We are on a mission to enable life-changing therapies to reach patients around the worldand we are looking for passionate individuals who embody our core values every day:Responsible, Responsive, Resilient, and Respect.
We are currently recruiting for aContracts Officer to join our Legal Contracts team. In this role you will be assisting the Legal Team with contract lifecycle management including ensuring the contracts database and filing systems are accurately completed
Your responsibilities in this role would be:
* Supporting the Legal Team by maintaining contracts database and filing systems
* Supporting the drafting of simple agreements with other parties based on template agreements and review third party templates.
* Manage signature process for finalised agreements using digital signature tools.
* Assisting the management of the Contracts email inbox, triage queries and filing as appropriate.
* Supporting contract databases and quality data entry including contract migration and bulk updates and other technical aspects.
* Providing regular information on status of agreements for both the Contracts/Legal Team and other managers within the company.
* Filing fully executed statements of work and change orders received from Commercial and Project Management Teams or other.
* Carry out document scanning and archiving, as necessary.
* Track agreement expiry dates and help with managing renewal process and notifications.
Profile description:
We are looking for:
* Good communication skills in English both written and verbal with strong attention to detail
* Educated to degree level or prior experience working in a contracts support role.
* Previous experience administrating in a regulated environment preferably legal.
* Proficient with MS Office-based tools, Word, Excel, Teams
* Demonstrable experience and understanding of the use of databases.
* Some appreciation in the use of AI within the administrative workplace.
* The ability to manage time and prioritise workload in delivery of work to timelines and deliverables.
* Demonstrate competency within a client centric and team working environment.
About Us:
OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 30 years of experience in viral vectors; the driving force behind the majority of gene therapies.
OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), and adenoviral vectors. OXBs world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.
Why Join Us?
* ??Competitive total reward packages
* ??Wellbeing programmesthat support your mental and physical health
* ??Career development opportunitiesto help you grow and thrive
* ??Supportive, inclusive, and collaborative culture
* ??State-of-the-art labs and manufacturing facilities
* ?? A company that lives its values:Responsible, Responsive, Resilient, Respect
We want you to feel inspired every day. At OXB, we are future-focused and growing fast. We succeed togetherthrough passion, commitment, and teamwork.
Ready to Make a Difference?
Collaborate. Contribute. Change lives.
We offer:
Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 30 years of experience in viral vectors, the driving force behind the majority of gene therapies.
Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).
Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
JBRP1_UKTJ